Article Sidebar

PDF
Issue: Vol. 523 No. 2 (2023)
Section: Các bài báo
DOI: 10.51298/vmj.v523i2.4533
Date Published: 28/02/2023
Views 432
Downloads 255
How to Cite
Lê, T. T. X., Nguyễn, V. T., Lê, T. T. H., Nguyễn, T. N., Hoàng, D. L., Nguyễn, T. H., Lê, T. H., Nguyễn, T. T., An, H. L., & Nguyễn, T. Q. (2023). PREVALENCE OF ADVERSE EFFECTS OF COVID-19 ASTRAZENECA VACCINE AMONG ADULTS AT HA NOI MEDICAL UNIVERSITY, 2021. Vietnam Medical Journal, 523(2). https://doi.org/10.51298/vmj.v523i2.4533

PREVALENCE OF ADVERSE EFFECTS OF COVID-19 ASTRAZENECA VACCINE AMONG ADULTS AT HA NOI MEDICAL UNIVERSITY, 2021

Thị Thanh Xuân Lê1, Văn Thành Nguyễn1, Thị Thanh Hà Lê1, Thúy Nam Nguyễn1, Diệu Linh Hoàng1, Thúy Hiền Nguyễn1, Thu Hường Lê1, Thị Thịnh Nguyễn1, Hồng Liên An1, Thị Quỳnh Nguyễn1
1 Hanoi medical university

Main Article Content

Abstract

Objectives: To describe the prevalence of adverse effects of the Covid-19 Astrazeneca vaccine among adults at Ha Noi Medical University in 2021. Method: A cross-sectional study was conducted on 773 people from October 2021 to October 2022. Results: the rate of local effects after in 1st dose was 24.58 %, 2nd dose was  23.42%. Common effects were tiredness (1st dose: 52.26%, 2nd dose: 16.56 %), increasing pain impress (1st dose:39.97%, 2nd dose: 15.39 %), fever < 38.5°C (1st dose: 31.31%, 2nd dose: 9.31%). The dangerous effects of Covid-19 Astrazeneca vaccine were very low. The adverse effects usually occurred from 1 to 24 hours after vaccination. Conclusion: The rate of the adverse effects of Covid-19 Astrazeneca vaccine among adults at Ha Noi Medical University in 2021 was relatively high, but mainly common effects such as fever, tiredness and increasing pain impress.

Keywords

Adverse effects, Covid-19 Astrazeneca vaccine, Ha Noi Medical University

Article Details

References

1. WHO Việt Nam. Vắc xin COVID-19 của Oxford/AstraZeneca: những điều cần biết. Accessed truy câp 8/11/2022, https://www.who.int/vietnam/vi/news/detail/19-04-2021-the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know
2. Muhammad Nauman Zahid. Unfolding the mild to moderate short-term side effects of four COVID-19 vaccines used in Bahrain: a cross-sectional study. Vaccines. 2021;9(11):1369.
3. Qianhui Wu, Matthew Z Dudley, Xinghui Chen, et al. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC medicine. 2021;19(1):1-16.
4. Tran VN, Nguyen HA, Le TTA, et al. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021. Vaccine. Oct 22 2021;39(44):6485-6491. doi:10.1016/j.vaccine.2021.09.060
5. Borobia AM, Carcas AJ, Pérez-Olmeda M, et al. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet (London, England). Jul 10 2021;398(10295):121-130. doi:10.1016/s0140-6736(21)01420-3
6. Nguyễn Văn Thành, Nguyễn Thuý Nam, Hoàng Diệu Linh. 27. Thực trạng phản ứng sau tiêm tại phòng tiêm chủng Trường Đại học Y Hà Nội giai đoạn 2015-2020. Tạp chí Nghiên cứu Y học. 2022;156(8):234-242.
7. Cristina Menni, Kerstin Klaser, Anna May, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases. 2021;21(7):939-949.